Breakthrough Therapy Designation a Runaway Success for CDER in 2013

Drug Industry Daily
A A
The FDA’s new breakthrough therapy designation has exploded in popularity, the agency says.

To View This Article:

Login

Subscribe To Drug Industry Daily